Dr. Parker’s primary interest is infectious diseases. For several years she has been engaged in randomized control trials funded by the NIH and the CDC. She engages in a multidisciplinary approach in the areas of both research and clinical practice. Translational research is incorporated into her work in order to improve the health outcomes of vulnerable populations. Dr. Parker is engaged in biomedical research examining the use of Pre-Exposure Prophylaxis (PrEP) with men who have sex with men (MSM) and heterosexual women to reduce the transmission of HIV among high-risk populations.
